Skip to Main Content

Advertisement intended for health care professionals

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

Issue Archive

Volume 128, Issue 15
October 13 2016
Issue Cover

Table of Contents

BLOOD FLASHBACK

Shreiner DP, Bell WR. Pseudothrombocytopenia: manifestation of a new type of platelet agglutinin. Blood. 1973;42(4):541-549.
View Articletitled, Shreiner DP, Bell WR. Pseudothrombocytopenia: manifestation of a new type of platelet agglutinin. <em>Blood</em>. 1973;42(4):<span class="related-article">541-549</span>.

INSIDE BLOOD COMMENTARIES

INSIDE BLOOD COMMENTARY
Iron rusting in the mitochondria?
Norbert Gattermann
View Articletitled, Iron rusting in the mitochondria?
INSIDE BLOOD COMMENTARY
CLL: an acquired immunodeficiency disease
Clive S. Zent
View Articletitled, CLL: an acquired immunodeficiency disease
INSIDE BLOOD COMMENTARY
Fighting fat in AML
Shaoguang Li
View Articletitled, Fighting fat in AML

PLENARY PAPER

Red Cells, Iron, and Erythropoiesis
A recurring mutation in the respiratory complex 1 protein NDUFB11 is responsible for a novel form of X-linked sideroblastic anemia
Brief Report
Daniel A. Lichtenstein,Andrew W. Crispin,Anoop K. Sendamarai,Dean R. Campagna,Klaus Schmitz-Abe,Cristovao M. Sousa,Martin D. Kafina,Paul J. Schmidt,Charlotte M. Niemeyer,John Porter,Alison May,Mrinal M. Patnaik,Matthew M. Heeney,Alec Kimmelman,Sylvia S. Bottomley,Barry H. Paw,Kyriacos Markianos,Mark D. Fleming
View Articletitled, A recurring mutation in the respiratory complex 1 protein NDUFB11 is responsible for a novel form of X-linked sideroblastic anemia
Supplemental data

REVIEW ARTICLE

BRAF V600E mutation in hairy cell leukemia: from bench to bedside
Clinical Trials & Observations
Brunangelo Falini,Maria Paola Martelli,Enrico Tiacci
View Articletitled, <em>BRAF</em> V600E mutation in hairy cell leukemia: from bench to bedside

HEMATOPOIESIS AND STEM CELLS

Identification of novel regulators of developmental hematopoiesis using Endoglin regulatory elements as molecular probes
Rabab Nasrallah,Eva M. Fast,Parham Solaimani,Kathy Knezevic,Alexia Eliades,Rahima Patel,Roshana Thambyrajah,Ashwin Unnikrishnan,Julie Thoms,Dominik Beck,Chris S. Vink,Aileen Smith,Jason Wong,Mairi Shepherd,David Kent,Rahul Roychoudhuri,Fabian Paul,Julia Klippert,Annette Hammes,Thomas Willnow,Bertie Göttgens,Elaine Dzierzak,Leonard I. Zon,George Lacaud,Valerie Kouskoff,John E. Pimanda
View Articletitled, Identification of novel regulators of developmental hematopoiesis using <em>Endoglin</em> regulatory elements as molecular probes
Supplemental data

LYMPHOID NEOPLASIA

Atypical Pneumocystis jirovecii pneumonia in previously untreated patients with CLL on single-agent ibrutinib
Clinical Trials & Observations Brief Report
Inhye E. Ahn,Theresa Jerussi,Mohammed Farooqui,Xin Tian,Adrian Wiestner,Juan Gea-Banacloche
View Articletitled, Atypical <em>Pneumocystis jirovecii</em> pneumonia in previously untreated patients with CLL on single-agent ibrutinib

MYELOID NEOPLASIA

Targeting FLT3-ITD signaling mediates ceramide-dependent mitophagy and attenuates drug resistance in AML
Mohammed Dany,Salih Gencer,Rose Nganga,Raquela J. Thomas,Natalia Oleinik,Kyla D. Baron,Zdzislaw M. Szulc,Peter Ruvolo,Steven Kornblau,Michael Andreeff,Besim Ogretmen
View Articletitled, Targeting FLT3-ITD signaling mediates ceramide-dependent mitophagy and attenuates drug resistance in AML
Supplemental data

THROMBOSIS AND HEMOSTASIS

N-linked glycans within the A2 domain of von Willebrand factor modulate macrophage-mediated clearance
Alain Chion,Jamie M. O’Sullivan,Clive Drakeford,Gudmundur Bergsson,Niall Dalton,Sonia Aguila,Soracha Ward,Padraic G. Fallon,Teresa M. Brophy,Roger J. S. Preston,Lauren Brady,Orla Sheils,Michael Laffan,Thomas A. J. McKinnon,James S. O’Donnell
View Articletitled, N-linked glycans within the A2 domain of von Willebrand factor modulate macrophage-mediated clearance
Supplemental data
The interaction between fibrinogen and zymogen FXIII-A2B2 is mediated by fibrinogen residues γ390-396 and the FXIII-B subunits
James R. Byrnes,Clare Wilson,Anthony M. Boutelle,Chase B. Brandner,Matthew J. Flick,Helen Philippou,Alisa S. Wolberg
View Articletitled, The interaction between fibrinogen and zymogen FXIII-A<sub>2</sub>B<sub>2</sub> is mediated by fibrinogen residues γ390-396 and the FXIII-B subunits
Supplemental data

TRANSPLANTATION

Matching for the nonconventional MHC-I MICA gene significantly reduces the incidence of acute and chronic GVHD
Raphael Carapito,Nicolas Jung,Marius Kwemou,Meiggie Untrau,Sandra Michel,Angélique Pichot,Gaëlle Giacometti,Cécile Macquin,Wassila Ilias,Aurore Morlon,Irina Kotova,Petya Apostolova,Annette Schmitt-Graeff,Anne Cesbron,Katia Gagne,Machteld Oudshoorn,Bronno van der Holt,Myriam Labalette,Eric Spierings,Christophe Picard,Pascale Loiseau,Ryad Tamouza,Antoine Toubert,Anne Parissiadis,Valérie Dubois,Xavier Lafarge,Myriam Maumy-Bertrand,Frédéric Bertrand,Luca Vago,Fabio Ciceri,Catherine Paillard,Sergi Querol,Jorge Sierra,Katharina Fleischhauer,Arnon Nagler,Myriam Labopin,Hidetoshi Inoko,Peter A. von dem Borne,Jürgen Kuball,Masao Ota,Yoshihiko Katsuyama,Mauricette Michallet,Bruno Lioure,Régis Peffault de Latour,Didier Blaise,Jan J. Cornelissen,Ibrahim Yakoub-Agha,Frans Claas,Philippe Moreau,Noël Milpied,Dominique Charron,Mohamad Mohty,Robert Zeiser,Gérard Socié,Seiamak Bahram
View Articletitled, Matching for the nonconventional MHC-I <em>MICA</em> gene significantly reduces the incidence of acute and chronic GVHD
Supplemental data

LETTERS TO BLOOD

First report of safety and efficacy of daratumumab in 2 cases of advanced immunoglobulin light chain amyloidosis
Taimur Sher,Brooke Fenton,Adnan Akhtar,Morie A. Gertz
View Articletitled, First report of safety and efficacy of daratumumab in 2 cases of advanced immunoglobulin light chain amyloidosis
An upper bound for the half-removal time of neutrophils from circulation
Morgan Craig,Antony R. Humphries,Michael C. Mackey
View Articletitled, An upper bound for the half-removal time of neutrophils from circulation

BLOOD WORK

Mott cell (Russell body) Barrett's esophagitis
Aruna Rangan,Daniel W. Visscher
View Articletitled, Mott cell (Russell body) Barrett's esophagitis
This is not an osteoclast
Adriana Plesa,Pierre Sujobert
View Articletitled, This is not an osteoclast

ERRATA

Taylor JA, Kruse-Jarres R. A new era for hemophilia B treatment. Blood. 2016;127(14):1734-1736.
View Articletitled, Taylor JA, Kruse-Jarres R. A new era for hemophilia B treatment. <em>Blood</em>. 2016;127(14):1734-1736.
All Issues

Advertisement intended for health care professionals

Licking the wound with procoagulant vesicles
Approaching Hypercalcemia in Monoclonal Gammopathy of Undetermined Significance: Insights from the iStopMM study
CAR T-cells in autoimmunity: game changer or stepping stone?
Long-Term Efficacy and Safety of Danicopan as Add-On Therapy to Ravulizumab or Eculizumab in PNH With Significant EVH
How I treat quantitative fibrinogen disorders

Advertisement intended for health care professionals

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals